Finding the optimal dose in Project Optimus Understanding your oncology asset and defining your possibilities
By Fortrea
Implementing Project Optimus requires overcoming several operational obstacles. Download this whitepaper to understand the challenges that oncology drug developers are facing with the implementation of Project Optimus and the strategies that can be used for dose modelling and simulation.
Project Optimus was first announced by the US FDA in 2021 and has since gained momentum as the regulator has provided further clarifications around the guidance and begun working closely with the industry in optimal dose-finding studies. Learn about the challenges of Project Optimus and the best strategies for studying advanced and combination oncology therapies in this whitepaper from Fortrea.